With over 2.7 million deaths reported so far, the novel coronavirus disease 2019 (COVID-19) pandemic has had an enormous impact
Read more
Home » antibodies »
antibodies
Infliximab may hinder the effectiveness of some COVID-19 vaccines
As many countries are being hit hard by repeated waves of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with
Read more
Linear epitope mapping of the SARS-CoV-2 spike protein
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery
Read more
New targets for antibodies in the fight against SARS-CoV-2
An international team of researchers examined the antibodies from a large cohort of COVID-19 patients. Due to the way antibodies
Read more
Most cancer patients with COVID-19 produce antibodies at a rate comparable to general population
Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest
Read more
tapering prevacid after long term use
Inactivated whole-cell vaccines, also known as ‘killed vaccines,’ are amongst the most traditionally employed varieties of vaccine, having been developed
Read more
Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19
A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from
Read more
Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients
Vaccines are very important in controlling the coronavirus disease 2019 (COVID-19) pandemic. Two highly effective mRNA vaccines are available in
Read more
Delaying second dose of Pfizer-BioNTech SARS-CoV-2 vaccine may be feasible in some cases
Researchers in Spain have conducted the most extensive study to date investigating the effectiveness of vaccinating healthcare workers with a
Read more
Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies
Extensive testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a primary mitigation measure in controlling
Read more